Jessica N. Abraham | Designer. Writer. Publicist.

19+ Years of Expertise in Digital Marketing, Social Branding and Public Relations.

  • Home
  • Contact
  • About
  • Home
  • Contact
  • About

No Widgets found in the Sidebar Alt!

  • Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life.
    Benzinga,  Biotechnology,  Health,  Nature,  Regenerative Medicine

    Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It

    June 15, 2022 /

    Originally Published on Benzinga Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life. The global regenerative medicine market  is estimated to reach $6.49 billion in 2027, up 9.3% from $3.05 billion in 2019. …

    read more
    Jessica N. Abraham Comments Off on Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It

    You May Also Like

    marijuana 3065612 1920 A new operation in Commerce, California is quickly becoming one of the world's largest next-generation cannabis production facilities. 

    Automating The Future Of Cannabis: How One Enterprise Wants To Lead The Charge Towards Large Scale Manufacturing

    March 8, 2022
    Worksport, Terravis Microgrids, Nanogrids, Solar and Hydrogen Clean Energy, Off-grid energy, grid-free energy

    Worksport Makes the Impossible Possible: Green-Energy Microgrid Systems Power EV Trucking and Off-Grid Lifestyling

    September 21, 2021
    Derivative trading, options trading, CFD, Contract for Derivatives, Trading stocks, Crypto trading, Leveraging margin

    A Look into Share CFDs and the Top 5 to Watch… Come Rise or Fall

    October 4, 2021
  • Statera Pharmaceuticals treatment for Covid-19 Long-Haulers
    Health,  Benzinga,  Biotechnology,  Business,  Finance

    Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2

    October 28, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Statera Biopharma, Inc. (NASDAQ: STAB) recently announced that it has officially received Institutional Review Board (IRB) approval to conduct a Phase 1 pilot study at Loma Linda University Health to evaluate STAT-205 as a treatment in the mitigation of SARS-CoV-2 progression. STAT-205 is a breakthrough immuno-modulator designed to decrease elevated inflammatory responses that are associated with viral infections and inhibit viral replication in human lung cells. Its efficacy was successfully demonstrated during preclinical in vitro studies, where STAT-205 was able to inhibit the replication of…

    read more
    Jessica N. Abraham Comments Off on Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2

    You May Also Like

    CBD Vape, Mood Management, Canopy Growth, Cannabis, Medical Cannabis, Mental Health, Toxic Free Vaping, Healthy Vaping, Health and Wellness,

    Change Your Mood with a Quick Hit: Canopy Growth Launches whisl, First-Ever CBD Vape

    September 15, 2021
    Generation Hemp, Industrial Hemp, Pet Bedding, Animal Bedding, Not Hay, Not Straw, Mold-Free, Pest-Free, Sustainable

    Rowdy Rooster Hemp Unleashed | Official Launch of Generation Hemp’s Animal Bedding Brand for Small Animals

    September 29, 2021
    What's the difference between Marijuana, Cannabis and Hemp -- industrial Hemp, CBD, Farm Bill, Agricultural Act, Generation Hemp, GENH

    Cannabis Investors Should Know the Difference Between Marijuana and Hemp

    July 19, 2021
  • Goats, Animal Bedding, anti-pest, anti-mold, anti-bacterial, industrial hemp industry,
    Animals,  Benzinga,  Business,  Cannabis,  Farming,  Finance,  Health,  Hemp,  Industry,  Nature

    Research Shows that Animals, too, Need a Good Night’s Sleep

    September 14, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. There’s a genetic link between narcolepsy, sleeping with one eye open and the so-called “fear conditioning” of so many different animals on this planet. A lack of sleep is not only dangerous to the health of humans but it also puts the health of these animals at risk, no matter their shape, size or species. Social hierarchy, diet, brain size and body mass are contributing factors to how much sleep particular animals naturally need. Outside factors might even include their immediate environment and a…

    read more
    Jessica N. Abraham Comments Off on Research Shows that Animals, too, Need a Good Night’s Sleep

    You May Also Like

    Generation Hemp, Industrial Hemp, Pet Bedding, Animal Bedding, Not Hay, Not Straw, Mold-Free, Pest-Free, Sustainable

    Rowdy Rooster Hemp Unleashed | Official Launch of Generation Hemp’s Animal Bedding Brand for Small Animals

    September 29, 2021
    Generation Hemp is a pure-play leader in the industrial hemp industry.

    Generation Hemp Reports Quarterly Financial Statements to SEC, Announces New Processing Contracts and Brand Launches

    August 21, 2021
    Green Policy, Generation Hemp, Melissa Pagen, Gary C Evans, Industrial Hemp Processor, Hemp Cleaning, Green Policy, ESG

    Generation Hemp’s Green Policy is Inspired by a Cause, Executives Move From Oil and Gas to Industrial Green

    August 30, 2021
  • Statera Biopharmaceuticals, Groundbreaking Biomedicine Treatment
    Health,  Benzinga,  Biotechnology,  Business,  Finance

    Statera BioPharma: The Ticker Formerly Known as CBLI

    September 7, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. On September 1, 2021, Cytocom officially became listed as Statera BioPharma, Inc. (NASDAQ: STAB), as it updated its ticker symbol from CLBI to STAB within the Nasdaq markets.  This change in name comes as a natural progression, as the company shifts gears toward placing a more strategic focus on restoring total immune health — including autoimmune and inflammatory diseases, such as fibromyalgia and multiple sclerosis, blood disorders like anemia and lupus, even cancer and various other infectious diseases.  The company began trading as CLBI, last month,…

    read more
    Jessica N. Abraham Comments Off on Statera BioPharma: The Ticker Formerly Known as CBLI

    You May Also Like

    Hemp-based animal bedding for small animals and farms -- pest free, pesticide free, mold-free, antibacterial, safe, edible.

    Industrial Hemp: Big Win for Pet Stores, Farmers, and Animals

    October 25, 2021
    Biotricity provides remote cardiac monitoring to patients through its biokit and Bioflux services. Biotricity's medtech technologies can be found in Samsung Watch4 devices and as a standalone platform at your local physical or health services provider.

    Biotricity Continues to Transform the Way We Do Health: Medtech Launches New Biokit Solution, Aims at Personal Health Monitoring

    September 15, 2021
    Age-Related Macular Degeneration DRY AMD, Lineage Cell Therapeutics

    Age-Related Macular Degeneration: What is Dry AMD, and How is Lineage Cell Therapeutics Changing the Game?

    August 11, 2021
  • Medtech Cardiac Monitoring Device, Wearable, Biotricity, Bioflux, Samsung, Watch4,
    Business,  Benzinga,  Finance,  Health,  IoT,  Medtech,  Technology,  Wearable Devices

    Biotricity Reports Q1 Earnings at 290% for FY2022

    September 2, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Biotricity (NASDAQ: BTCY) has been taking the world of medtech by storm, introducing primary care providers across the country to its remote heart monitoring devices. Always connected, these wearable devices have been giving power back to those suffering from chronic cardiac conditions and simultaneous comorbidities — the simultaneous presence of two or more diseases or medical conditions and often relative of one another.  Through remote heart monitoring and diagnostic technologies, doctors can screen their patients from a distance, even alerted to a possible emergency if the…

    read more
    Jessica N. Abraham Comments Off on Biotricity Reports Q1 Earnings at 290% for FY2022

    You May Also Like

    Workforce Optimization, Covid-19, Coronavirus, Remote Teams, Team Building, DISC Insights, PeopleKeys, Personality Types, Management, Leadership

    Optimizing Your Remote Workforce in Times of Crisis

    March 16, 2020
    Weather Trader, Stock Market, Global Stocks, Weather, Accuweather, Predictions 2021, Randall Peterson, Sterling K Brown, This is Us

    AccuWeatherIQ — The Randall Pearson of brands and advertisers

    September 5, 2019
    DORA Metrics -- The State of DevOps 2022, DORA Metrics, Development Velocity, Deployment Frequency, Lead time to Change, MTTR, Mean time to resolution, Change Failure Rate, Reliability, SPACE Framework, Developer Productivity Engineering, Jellyfish, Sleuth, LinearB,

    Startup Obtains Industry-Leading Certification, Continues Focus On The Future Of Engineering Excellence

    November 11, 2022
 Older Posts
  • Business
  • Technology
  • Career Development
  • Education
  • Entertainment
  • Fashion
  • Relationships
  • Tips
  • Travel
Ashe Theme by WP Royal.